Jaw-Ji Tsai Selected Research

Dermatophagoides pteronyssinus antigen p 2

1/2015	Cell-penetrating peptide derived from human eosinophil cationic protein inhibits mite allergen Der p 2 induced inflammasome activation.
12/2014	Der p 2 can induce bystander activation of B cells derived from patients with systemic lupus erythematosus.
10/2014	House dust mite allergy: environment evaluation and disease prevention.
4/2013	Detection of group 2 Dermatophagoides pteronyssinus allergen for environmental monitoring of dust mite infestation.
10/2005	Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaw-Ji Tsai Research Topics

Disease

17	Inflammation (Inflammations) 01/2022 - 09/2002
13	Hypersensitivity (Allergy) 01/2022 - 12/2003
5	Asthma (Bronchial Asthma) 01/2015 - 04/2007
3	Allergic Rhinitis 11/2011 - 03/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2014 - 07/2009
2	Mite Infestations (Mange) 10/2014 - 04/2013
2	Respiratory Hypersensitivity 08/2003 - 06/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Lung Injury 01/2022
1	Immediate Hypersensitivity 01/2021
1	Infections 01/2017
1	Rheumatoid Arthritis 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Chronic Urticaria 07/2014
1	Skin Neoplasms (Skin Cancer) 03/2012
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2012
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2010
1	Stroke (Strokes) 12/2009
1	Diabetes Mellitus 12/2009
1	Neurologic Manifestations (Neurological Manifestations) 12/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2009
1	Bites and Stings (Sting) 01/2009

Drug/Important Bio-Agent (IBA)

15	AllergensIBA 01/2022 - 09/2002
7	Immunoglobulin E (IgE)IBA 09/2020 - 01/2009
7	CytokinesIBA 01/2017 - 09/2002
5	Dermatophagoides pteronyssinus antigen p 2IBA 01/2015 - 10/2005
4	Peptides (Polypeptides)IBA 01/2022 - 08/2003
4	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 08/2003
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2009
2	P-2 (P 2)IBA 09/2020 - 10/2005
2	Complex MixturesIBA 09/2020 - 06/2018
2	Eosinophil Cationic ProteinIBA 01/2017 - 04/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2009
2	Immunoglobulin A (IgA)IBA 10/2014 - 10/2005
2	Biomarkers (Surrogate Marker)IBA 11/2010 - 01/2010
2	Therapeutic UsesIBA 01/2007 - 12/2003
2	Immunoglobulins (Immunoglobulin)IBA 10/2005 - 09/2002
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	indium-bleomycinIBA 01/2022
1	Caseins (Casein)FDA Link 02/2017
1	GlucocorticoidsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-13IBA 01/2017
1	Cell-Penetrating PeptidesIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	InflammasomesIBA 01/2015
1	Monoclonal AntibodiesIBA 10/2014
1	Pattern Recognition ReceptorsIBA 10/2014
1	Dermatophagoides pteronyssinus antigen p 1IBA 10/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2014
1	Dust (House Dust)FDA Link 04/2013
1	Imiquimod (Aldara)FDA LinkGeneric 03/2012
1	SulfitesIBA 10/2011
1	Sulfur DioxideIBA 10/2011
1	sodium sulfite (sodium sulphite)IBA 10/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011
1	Vitamin E FDA LinkGeneric 11/2010
1	Interleukin-5 (Interleukin 5)IBA 11/2010
1	Interleukin-8 (Interleukin 8)IBA 11/2010
1	ChemokinesIBA 11/2010
1	Chemokine CCL5IBA 11/2010
1	LeptinIBA 11/2010
1	AdiponectinIBA 11/2010
1	AdipokinesIBA 11/2010
1	Ribonucleases (Ribonuclease)IBA 01/2010
1	Serum AlbuminIBA 12/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2009
1	LipidsIBA 12/2009
1	Triglycerides (Triacylglycerol)IBA 12/2009
1	CholesterolIBA 12/2009
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2009
1	Dermatophagoides farinae antigen f 2IBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Immunoglobulin G (IgG)IBA 01/2009
1	Immunologic Factors (Immunomodulators)IBA 12/2003
1	Tuberculin (PPD)IBA 06/2002

Therapy/Procedure

8	Immunotherapy 01/2022 - 06/2002
2	Immunomodulation 01/2022 - 10/2014
2	Therapeutics 01/2017 - 12/2003
1	Home Nursing (Nursing, Home) 01/2010
1	Secondary Prevention 12/2003